Polylactide nanocapsules attenuate adverse cardiac cellular effects of Lyso-7, a Pan-PPAR agonist/anti-inflammatory new thiazolidinedione
Giani Martins Garcia Jérôme Roy; Ivan R Pitta; Dulcinéia Saes Parra Abdalla; Andrea Grabe Guimarães; Vanessa Carla Furtado Mosqueira; Sylvain Richard
Pharmaceutics Basel v. 13, p. 1-13 art. 1521, 2021Basel 2021
Item não circula. Consulte sua biblioteca.(Acessar)